Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
248.50    0.00 (0.00%)
Bid:
241.50
Ask:
245.00
Spread: 3.50 (1.449%)
Market Cap: £144.97m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Trading Update

9 Jul 2020 07:00

RNS Number : 4622S
MJ Gleeson PLC
09 July 2020
 

MJ Gleeson plc (GLE.L)

("Gleeson", "the Company" or "the business")

 

For immediate release

 

 

9 July 2020

 

Notice of Results & Trading Update

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, today provides an update for the year ended 30 June 2020 ("FY2020"). The Company will report its audited full year results on Monday, 14 September 2020.

 

Gleeson Homes

 

Gleeson Homes completed the sale of 1,072 homes during the year, a reduction of 29.9% compared with the previous year's total of 1,529.

 

However, the division has entered the new financial year ("FY2021") in a strong position with a forward order book standing at £145.3m on 1,033 plots (June 2019: £87.6m on 677 plots) and over 1,000 built or part-built homes.

 

Net daily reservations over the last four weeks have risen to more than 80% of pre Covid-19 levels with the majority reserved at prices higher than in January and February 2020.

 

Four new build sites were opened in the last two months of the year bringing the total build sites to 71. Of these sites, 65 are actively selling. The business plans to open more than 25 new sites during FY2021 year and expects to have at least 80 active build sites by the end of the period.

 

Current safe-working protocols are, as expected, having an impact on productivity and build rate. Build activity on sites is currently running at 60% of pre Covid-19 levels and is expected to reach 80% by September 2020.

 

The land pipeline of owned and conditionally purchased plots at 30 June 2020 increased by 1.7% compared to the prior year end, totaling 13,801 plots on 149 sites, of which 6,952 plots have been purchased subject to planning permission.

 

Gleeson Strategic Land

 

During the year Gleeson Strategic Land sold two land interests with the potential to deliver 195 plots for housing development.

 

The division's total portfolio comprises 68 sites, with the potential to deliver 23,314 plots, and 44 acres of commercial land. Of these, planning permission has been granted on 11 sites that have the potential to deliver 3,855 plots (June 2019: 9 sites, 2,929 plots).

 

Prior to Covid-19, the division was seeing strong interest in its consented sites. As the land market reopens this interest is returning, with enquiries from a broad range of housebuilders.

 

Group

 

The Group ended the year with cash balances of £76.8m including £60m drawn on the Company's committed bank facility (30 June 2019: £30.3m net cash). In addition, the Group has a £10m committed overdraft facility which is currently undrawn.

 

The majority of furloughed staff have returned to work, either to site or working from home, and the voluntary management pay cuts introduced in April were reversed on 1 July. No further use of the furlough scheme is anticipated after July.

 

The Board expects the results for FY2020 to be in line with revised market expectations.

 

 

James Thomson, Chief Executive Officer, commented:

 

"The impact of Covid-19 on the FY2020 results is as expected. What is pleasing is that the business has demonstrated its underlying resilience in the face of enormous challenges and we are starting the new financial year in a strong position."

 

"Gleeson Strategic Land's pipeline is strong and housebuilders are returning to the market to acquire much-needed consented land which remains in short supply."

 

"Buying a high-quality affordable Gleeson home remains substantially cheaper than renting - often poor quality - accommodation. With strong demand and reservation levels expected to soon recover to pre Covid-19 levels, our robust pipeline will enable us to open more sites than ever as we continue to deliver on our strategic plan of completing 2,000 homes p.a. in FY2022."

 

"We are confident that, if the current market improvement continues, the Group will see a rapid recovery in FY2021."

 

 

 

Enquiries:

 

 

 

MJ Gleeson plc

James Thomson

Stefan Allanson

 

Chief Executive Officer

Chief Financial Officer

01142 612900

Instinctif

Mark Garraway

Rosie Driscoll

 

07771 860938

07891 564641

N+1 Singer

Shaun Dobson

Rachel Hayes

020 7496 3000

Liberum

Neil Patel

Richard Bootle

 

020 3100 2222

 

 

This announcement is released by MJ Gleeson plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this information is considered to be in the public domain.

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUPUAUMUPUGBR
Date   Source Headline
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding
1st Jul 20227:05 amRNSMJ Gleeson achieves medium-term strategic target
30th Jun 20227:00 amRNSTotal Voting Rights
8th Jun 20222:53 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSTotal Voting Rights
12th May 20227:00 amRNSNotice of Trading Update & Results
10th May 20229:54 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSAppointment of Group Sustainability Manager
4th May 20221:09 pmRNSDirector/PDMR Shareholding
29th Apr 20223:30 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSRe Directorate Change
12th Apr 20224:51 pmRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSRe DLUHC pledge
31st Mar 20227:00 amRNSTotal Voting Rights
25th Mar 20227:00 amRNSDirectorate changes and committee appointments
17th Mar 20227:00 amRNSDirectorate Change
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
10th Mar 20229:54 amRNSDirector/PDMR Shareholding
10th Feb 20227:00 amRNSHalf-year Report
8th Feb 20224:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.